Modern surgical oncology continues to evolve rapidly through the integration of evidence-based, minimally invasive techniques that offer new therapeutic horizons. We are pleased to share the highlights from the highly successful “Advanced PIPAC Workshop: Clinical Application & Live Surgery,” held on September 7–8, 2026, at the IASO General Clinic in Athens.
Reshaping the Treatment of Peritoneal Malignancy
The PIPAC (Pressurized IntraPeritoneal Aerosol Chemotherapy) method is fundamentally changing the therapeutic approach to peritoneal malignancy. During this intensive two-day course, international clinical experience was directly translated into everyday practice.
Key takeaways from the workshop included:
- Precise Patient Selection: Comprehensive analysis of the clinical criteria required to identify patients who will benefit most from this targeted therapy.
- Live Surgery Sessions: Real-time application of the PIPAC technique in the operating room, providing invaluable, hands-on educational value to the participating surgeons.
- Global Expertise: The seamless exchange of advanced clinical practices and the latest scientific data among international specialists.
Expert Leadership and Collaboration
The workshop was hosted at the state-of-the-art IASO Cytoreductive Surgery & HIPEC/PIPAC Center. Dr. Andreas V. Larentzakis (MD, MSc, PhD, FACS, FESSO, ESPSO), Head of the Peritoneal Malignancy Surgical Oncology Program and Scientific Head of the CRS/HIPEC Center, served as the Course Director, successfully guiding the scientific direction and execution of the event.
Flawless technological support for the workshop was made possible by the equipment manufacturer REGER and its exclusive distributor, Inno Medical.
Continuous medical education and the prompt adoption of pioneering methods like PIPAC remain at the core of our commitment to delivering the most advanced, effective care to oncology patients.
#iaso #generalclinic #iasogenikikliniki #expertise #SurgicalOncology #PIPAC #HIPEC #RegerMedical #MedicalEducation
